Please login to the form below

Not currently logged in
Email:
Password:

insulin icodec

This page shows the latest insulin icodec news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk’s insulin icodec shows promise as once-weekly type 2 diabetes treatment

Novo Nordisk’s insulin icodec shows promise as once-weekly type 2 diabetes treatment

Insulin icodec is a novel once-weekly basal insulin analogue designed to cover the basal insulin requirements for a full week with a single subcutaneous injection. ... The trial achieved its primary endpoint of demonstrating non-inferiority in reducing

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...